Back to GetFilings.com




SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 


 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2004

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from              to             

 

Commission file number: 0-25317

 


 

INVITROGEN CORPORATION

(Exact name of registrant as specified in its charter)

 


 

Delaware   33-0373077

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

1600 Faraday Avenue, Carlsbad, CA   92008
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (760) 603-7200

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨.

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act).    Yes  x   or     No  ¨

 

As of October 31, 2004, there were 51,230,372 shares of the registrant’s Common Stock, par value $.01 per share, outstanding.

 



PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

 

INVITROGEN CORPORATION

CONSOLIDATED BALANCE SHEETS

(Dollars in thousands, except par value data)

 

     September 30,
2004


   

December 31,

2003


 
     (Unaudited)        
ASSETS                 

Current Assets:

                

Cash and cash equivalents

   $ 363,558     $ 588,678  

Short-term investments

     558,618       403,427  

Restricted cash and investments

     17,589       6,632  

Trade accounts receivable, net of allowance for doubtful accounts of $5,661 and $4,129, respectively

     162,588       117,095  

Inventories

     117,885       126,707  

Deferred income tax assets

     28,141       19,310  

Prepaid expenses and other current assets

     42,397       25,495  
    


 


Total current assets

     1,290,776       1,287,344  

Long-term investments

     126,282       177,070  

Property and equipment, net

     209,266       186,231  

Goodwill

     1,420,655       983,407  

Intangible assets, net

     428,969       464,659  

Other assets

     70,775       66,978  
    


 


Total assets

   $ 3,546,723     $ 3,165,689  
    


 


LIABILITIES AND STOCKHOLDERS’ EQUITY                 

Current Liabilities:

                

Current portion of long-term obligations

   $ 18,385     $ 1,784  

Accounts payable

     56,629       55,745  

Accrued expenses and other current liabilities

     94,651       65,406  

Income taxes

     13,586       2,758  
    


 


Total current liabilities

     183,251       125,693  

Long-term obligations, deferred credits and reserves

     36,098       32,069  

Pension liabilities

     17,416       17,249  

Deferred income tax liabilities

     159,601       161,331  

Convertible debt

     1,300,000       1,022,500  
    


 


Total liabilities

     1,696,366       1,358,842  
    


 


Commitments and contingencies

                

Stockholders’ Equity:

                

Preferred stock; $0.01 par value, 6,405,884 shares authorized; no shares issued or outstanding

     —         —    

Common stock; $0.01 par value, 125,000,000 shares authorized; 55,959,334 and 54,595,766 shares issued, respectively

     559       546  

Additional paid-in-capital

     2,009,946       1,942,756  

Deferred compensation

     (12,267 )     (11,265 )

Accumulated other comprehensive income

     56,444       56,158  

Accumulated deficit

     (26,133 )     (84,494 )

Less cost of treasury stock; 4,831,562 and 3,201,451 shares, respectively

     (178,192 )     (96,854 )
    


 


Total stockholders’ equity

     1,850,357       1,806,847  
    


 


Total liabilities and stockholders’ equity

   $ 3,546,723     $ 3,165,689  
    


 


 

The accompanying notes are an integral part of these consolidated financial statements.

 

2


INVITROGEN CORPORATION

CONSOLIDATED STATEMENTS OF INCOME

(Amounts in thousands, except per share data)

 

    

For the Three Months

Ended September 30,


   

For the Nine Months

Ended September 30,


 
     2004

    2003

    2004

    2003

 
     (Unaudited)     (Unaudited)  

Revenues

   $ 256,328     $ 196,939     $ 761,616     $ 569,968  

Cost of revenues

     99,123       77,159       316,393       222,122  
    


 


 


 


Gross profit

     157,205       119,780       445,223       347,846  
    


 


 


 


Operating expenses:

                                

Sales and marketing

     45,614       38,457       134,329       113,325  

General and administrative

     27,596       22,722       80,825       65,383  

Research and development

     19,214       15,354       53,116       38,543  

Purchased intangibles amortization

     25,004       20,736       81,539       56,243  

Purchased in-process research and development

     —         1,410       728       1,410  

Business integration costs

     —         925       —         1,318  
    


 


 


 


Total operating expenses

     117,428       99,604       350,537       276,222  
    


 


 


 


Operating income

     39,777       20,176       94,686       71,624  
    


 


 


 


Other income (expense), net:

                                

Interest income

     6,417       5,939       17,837       17,973  

Interest expense

     (7,401 )     (7,547 )     (24,602 )     (20,249 )

Loss on early retirement of debt

     —         —         (6,775 )     —    

Other income (expense), net

     (315 )     (103 )     (315 )     233  
    


 


 


 


Total other income (expense), net

     (1,299 )     (1,711 )     (13,855 )     (2,043 )
    


 


 


 


Income before provision for income taxes and minority interest

     38,478       18,465       80,831       69,581  

Provision for income taxes

     (10,315 )     (4,767 )     (22,470 )     (21,431 )

Minority interest

     —         —         —         (609 )
    


 


 


 


Net income

   $ 28,163     $ 13,698     $ 58,361     $ 47,541  
    


 


 


 


Earnings per common share:

                                

Basic

   $ 0.54     $ 0.27     $ 1.13     $ 0.95  
    


 


 


 


Diluted

   $ 0.52     $ 0.26     $ 1.09     $ 0.94  
    


 


 


 


Weighted average shares used in per share calculation:

                                

Basic

     51,748       50,298       51,876       50,118  

Diluted

     58,694       51,762       59,403       50,822  

 

The accompanying notes are an integral part of these consolidated financial statements.

 

3


INVITROGEN CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in thousands)

 

    

For the Nine Months

Ended September 30,


 
     2004

    2003

 
     (Unaudited)  

CASH FLOWS FROM OPERATING ACTIVITIES:

                

Net income

   $ 58,361     $ 47,541  

Adjustments to reconcile net income to net cash provided by operating activities, net of effects of businesses acquired:

                

Depreciation

     27,254       19,900  

Amortization of intangible assets

     84,007       58,569  

Amortization of deferred debt issue costs

     2,601       2,536  

Amortization of premiums on investments, net of accretion of discounts

     6,086       8,256  

Amortization of deferred compensation

     3,206       632  

Deferred income taxes

     (28,940 )     (20,992 )

Other non-cash adjustments

     10,335       7,025  

Changes in operating assets and liabilities:

                

Trade accounts receivable

     (23,275 )     (15,009 )

Inventories

     11,206       (1,946 )

Prepaid expenses and other current assets

     4,771       (1,764 )

Other assets

     (204 )     1,748  

Accounts payable

     (13,020 )     3,348  

Accrued expenses and other current liabilities

     6,666       13,053  

Income taxes

     20,408       1,818  
    


 


Net cash provided by operating activities

     169,462       124,715  
    


 


CASH FLOWS FROM INVESTING ACTIVITIES:

                

Maturities of available-for-sale securities

     764,994       —    

Purchases of available-for-sale securities

     (877,401 )     —    

Maturities of held-to-maturity securities

     —         235,539  

Purchases of held-to-maturity securities

     —         (263,278 )

Cash paid for business combinations, net of cash acquired

     (491,380 )     (412,943 )

Purchases of property and equipment

     (19,703 )     (19,893 )

Proceeds from sale of property and equipment

     1,329       2,716  

Payments for intangible assets

     (1,599 )     (478 )
    


 


Net cash used in investing activities

     (623,760 )     (458,337 )